Which has preferable valuation & earnings, CANG or DAVA?

Endava has higher revenue and earnings than Cango. Endava is trading at a lower price-to-earnings ratio than Cango, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cango $688.08M 0.05 -$621.95M -$3.56 N/A Endava $999.23M 0.16 $27.45M -$10.51 N/A

Is CANG or DAVA more profitable?

Endava has a net margin of -57.01% compared to Cango's net margin of -125.53%. Endava's return on equity of 2.58% beat Cango's return on equity. Company Net Margins Return on Equity Return on Assets Cango -125.53% -105.01% -51.46% Endava -57.01% 2.58% 1.45%

Do analysts recommend AMBR or CANG?

Cango has a consensus price target of $3.00, indicating a potential upside of 1,416.68%. Given Cango's stronger consensus rating and higher possible upside, analysts clearly believe Cango is more favorable than Amber International. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Amber International 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Cango 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.50

Which has better valuation & earnings, AMBR or CANG?

Amber International has higher earnings, but lower revenue than Cango. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Amber International $66.09M 2.14 $3.75M N/A N/A Cango $688.08M 0.05 -$621.95M -$3.56 N/A

Does the media prefer AMBR or CANG?

In the previous week, Amber International had 1 more articles in the media than Cango. MarketBeat recorded 2 mentions for Amber International and 1 mentions for Cango. Amber International's average media sentiment score of 1.89 beat Cango's score of 0.00 indicating that Amber International is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Amber International 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Cango 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Is HCAT or CANG more profitable?

Health Catalyst has a net margin of -87.69% compared to Cango's net margin of -125.53%. Health Catalyst's return on equity of -3.52% beat Cango's return on equity. Company Net Margins Return on Equity Return on Assets Health Catalyst -87.69% -3.52% -1.77% Cango -125.53% -105.01% -51.46%

Does the media prefer HCAT or CANG?

In the previous week, Health Catalyst had 4 more articles in the media than Cango. MarketBeat recorded 5 mentions for Health Catalyst and 1 mentions for Cango. Health Catalyst's average media sentiment score of 0.44 beat Cango's score of 0.00 indicating that Health Catalyst is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Health Catalyst 0 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Cango 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has preferable earnings & valuation, CANG or EXFY?

Expensify has lower revenue, but higher earnings than Cango. Expensify is trading at a lower price-to-earnings ratio than Cango, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cango $688.08M 0.05 -$621.95M -$3.56 N/A Expensify $140.00M 0.98 -$21.39M -$0.23 N/A

Is CANG or EXFY more profitable?

Expensify has a net margin of -14.68% compared to Cango's net margin of -125.53%. Expensify's return on equity of -15.26% beat Cango's return on equity. Company Net Margins Return on Equity Return on Assets Cango -125.53% -105.01% -51.46% Expensify -14.68% -15.26% -10.96%

Does the media favor CANG or EXFY?

In the previous week, Expensify had 2 more articles in the media than Cango. MarketBeat recorded 3 mentions for Expensify and 1 mentions for Cango. Expensify's average media sentiment score of 0.63 beat Cango's score of 0.00 indicating that Expensify is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cango 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Expensify 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Cango (CANG) Competitors

$0.20 -0.01 (-4.95%)

Closing price 06/26/2026 03:59 PM Eastern

Extended Trading

$0.20 +0.00 (+1.11%)

As of 06/26/2026 07:40 PM Eastern

Compare

CANG vs. DAVA, AMBR, DOYU, HCAT, and EXFY

Should you buy Cango stock or one of its competitors? MarketBeat compares Cango with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Cango include Endava (DAVA), Amber International (AMBR), DouYu International (DOYU), Health Catalyst (HCAT), and Expensify (EXFY). These companies are all part of the "computer software" industry.

How does Cango compare to Endava?

Cango (NYSE:CANG) and Endava (NYSE:DAVA) are both small-cap computer and technology companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, analyst recommendations, earnings, dividends, risk, institutional ownership, media sentiment and valuation.

4.2% of Cango shares are held by institutional investors. Comparatively, 62.2% of Endava shares are held by institutional investors. 29.1% of Cango shares are held by insiders. Comparatively, 18.8% of Endava shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Cango had 1 more articles in the media than Endava. MarketBeat recorded 1 mentions for Cango and 0 mentions for Endava. Cango's average media sentiment score of 0.00 equaled Endava'saverage media sentiment score.

Company	Overall Sentiment
Cango	Neutral
Endava	Neutral

Endava has higher revenue and earnings than Cango. Endava is trading at a lower price-to-earnings ratio than Cango, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cango	$688.08M	0.05	-$621.95M	-$3.56	N/A
Endava	$999.23M	0.16	$27.45M	-$10.51	N/A

Cango currently has a consensus price target of $3.00, suggesting a potential upside of 1,416.68%. Endava has a consensus price target of $7.43, suggesting a potential upside of 159.02%. Given Cango's stronger consensus rating and higher possible upside, equities analysts clearly believe Cango is more favorable than Endava.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cango	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50
Endava	3 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	1.89

Endava has a net margin of -57.01% compared to Cango's net margin of -125.53%. Endava's return on equity of 2.58% beat Cango's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cango	-125.53%	-105.01%	-51.46%
Endava	-57.01%	2.58%	1.45%

Cango has a beta of 0.97, indicating that its share price is 3% less volatile than the broader market. Comparatively, Endava has a beta of 1.05, indicating that its share price is 5% more volatile than the broader market.

Summary

Endava beats Cango on 9 of the 16 factors compared between the two stocks.

How does Cango compare to Amber International?

Amber International (NASDAQ:AMBR) and Cango (NYSE:CANG) are both small-cap computer software companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, valuation, institutional ownership, earnings, profitability, risk, analyst recommendations and dividends.

Cango has a consensus price target of $3.00, indicating a potential upside of 1,416.68%. Given Cango's stronger consensus rating and higher possible upside, analysts clearly believe Cango is more favorable than Amber International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Amber International	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Cango	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50

Amber International has higher earnings, but lower revenue than Cango.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Amber International	$66.09M	2.14	$3.75M	N/A	N/A
Cango	$688.08M	0.05	-$621.95M	-$3.56	N/A

In the previous week, Amber International had 1 more articles in the media than Cango. MarketBeat recorded 2 mentions for Amber International and 1 mentions for Cango. Amber International's average media sentiment score of 1.89 beat Cango's score of 0.00 indicating that Amber International is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Amber International	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Cango	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

4.2% of Cango shares are owned by institutional investors. 15.1% of Amber International shares are owned by insiders. Comparatively, 29.1% of Cango shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Amber International has a net margin of -1.43% compared to Cango's net margin of -125.53%. Amber International's return on equity of -0.72% beat Cango's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Amber International	-1.43%	-0.72%	-0.29%
Cango	-125.53%	-105.01%	-51.46%

Amber International has a beta of 0.57, indicating that its stock price is 43% less volatile than the broader market. Comparatively, Cango has a beta of 0.97, indicating that its stock price is 3% less volatile than the broader market.

Summary

Amber International and Cango tied by winning 7 of the 14 factors compared between the two stocks.

How does Cango compare to DouYu International?

Cango (NYSE:CANG) and DouYu International (NASDAQ:DOYU) are both small-cap computer software companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, analyst recommendations, earnings, institutional ownership, media sentiment and risk.

In the previous week, Cango and Cango both had 1 articles in the media. DouYu International's average media sentiment score of 1.89 beat Cango's score of 0.00 indicating that DouYu International is being referred to more favorably in the news media.

Company	Overall Sentiment
Cango	Neutral
DouYu International	Very Positive

DouYu International has a net margin of 2.11% compared to Cango's net margin of -125.53%. DouYu International's return on equity of 4.60% beat Cango's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cango	-125.53%	-105.01%	-51.46%
DouYu International	2.11%	4.60%	2.94%

DouYu International has higher revenue and earnings than Cango. Cango is trading at a lower price-to-earnings ratio than DouYu International, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cango	$688.08M	0.05	-$621.95M	-$3.56	N/A
DouYu International	$3.69B	0.04	-$4.16M	$0.36	12.75

Cango presently has a consensus target price of $3.00, suggesting a potential upside of 1,416.68%. DouYu International has a consensus target price of $5.20, suggesting a potential upside of 13.29%. Given Cango's stronger consensus rating and higher probable upside, equities analysts plainly believe Cango is more favorable than DouYu International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cango	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50
DouYu International	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Cango has a beta of 0.97, meaning that its share price is 3% less volatile than the broader market. Comparatively, DouYu International has a beta of 0.86, meaning that its share price is 14% less volatile than the broader market.

4.2% of Cango shares are owned by institutional investors. Comparatively, 17.9% of DouYu International shares are owned by institutional investors. 29.1% of Cango shares are owned by insiders. Comparatively, 17.3% of DouYu International shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

DouYu International beats Cango on 9 of the 16 factors compared between the two stocks.

How does Cango compare to Health Catalyst?

Health Catalyst (NASDAQ:HCAT) and Cango (NYSE:CANG) are both small-cap computer software companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, dividends, profitability, media sentiment, valuation, institutional ownership, earnings and analyst recommendations.

In the previous week, Health Catalyst had 4 more articles in the media than Cango. MarketBeat recorded 5 mentions for Health Catalyst and 1 mentions for Cango. Health Catalyst's average media sentiment score of 0.44 beat Cango's score of 0.00 indicating that Health Catalyst is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Health Catalyst	0 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Cango	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Health Catalyst currently has a consensus target price of $2.84, indicating a potential upside of 49.52%. Cango has a consensus target price of $3.00, indicating a potential upside of 1,416.68%. Given Cango's stronger consensus rating and higher probable upside, analysts clearly believe Cango is more favorable than Health Catalyst.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Health Catalyst	1 Sell rating(s)	8 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.23
Cango	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50

Health Catalyst has a net margin of -87.69% compared to Cango's net margin of -125.53%. Health Catalyst's return on equity of -3.52% beat Cango's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Health Catalyst	-87.69%	-3.52%	-1.77%
Cango	-125.53%	-105.01%	-51.46%

Health Catalyst has a beta of 1.66, suggesting that its stock price is 66% more volatile than the broader market. Comparatively, Cango has a beta of 0.97, suggesting that its stock price is 3% less volatile than the broader market.

85.0% of Health Catalyst shares are owned by institutional investors. Comparatively, 4.2% of Cango shares are owned by institutional investors. 19.4% of Health Catalyst shares are owned by insiders. Comparatively, 29.1% of Cango shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Health Catalyst has higher earnings, but lower revenue than Cango. Health Catalyst is trading at a lower price-to-earnings ratio than Cango, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Health Catalyst	$311.14M	0.45	-$177.97M	-$3.72	N/A
Cango	$688.08M	0.05	-$621.95M	-$3.56	N/A

Summary

Health Catalyst beats Cango on 10 of the 17 factors compared between the two stocks.

How does Cango compare to Expensify?

Cango (NYSE:CANG) and Expensify (NASDAQ:EXFY) are both small-cap computer software companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, risk, valuation, analyst recommendations, dividends, earnings and profitability.

In the previous week, Expensify had 2 more articles in the media than Cango. MarketBeat recorded 3 mentions for Expensify and 1 mentions for Cango. Expensify's average media sentiment score of 0.63 beat Cango's score of 0.00 indicating that Expensify is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cango	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Expensify	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Cango has a beta of 0.97, indicating that its share price is 3% less volatile than the broader market. Comparatively, Expensify has a beta of 1.79, indicating that its share price is 79% more volatile than the broader market.

Expensify has a net margin of -14.68% compared to Cango's net margin of -125.53%. Expensify's return on equity of -15.26% beat Cango's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cango	-125.53%	-105.01%	-51.46%
Expensify	-14.68%	-15.26%	-10.96%

4.2% of Cango shares are held by institutional investors. Comparatively, 68.4% of Expensify shares are held by institutional investors. 29.1% of Cango shares are held by company insiders. Comparatively, 11.7% of Expensify shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Cango currently has a consensus price target of $3.00, indicating a potential upside of 1,416.68%. Expensify has a consensus price target of $2.50, indicating a potential upside of 53.94%. Given Cango's stronger consensus rating and higher probable upside, equities research analysts clearly believe Cango is more favorable than Expensify.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cango	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50
Expensify	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Expensify has lower revenue, but higher earnings than Cango. Expensify is trading at a lower price-to-earnings ratio than Cango, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cango	$688.08M	0.05	-$621.95M	-$3.56	N/A
Expensify	$140.00M	0.98	-$21.39M	-$0.23	N/A

Summary

Expensify beats Cango on 10 of the 17 factors compared between the two stocks.

Get Cango News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CANG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CANG vs. The Competition

Export

Metric	Cango	INTERNET SERVICES Industry	Computer Sector	NYSE Exchange
Market Cap	$36.97M	$158.08B	$37.89B	$23.23B
Dividend Yield	N/A	4.27%	3.31%	4.10%
P/E Ratio	-0.06	19.03	79.65	31.64
Price / Sales	0.05	50.84	623.58	109.21
Price / Cash	N/A	23.16	45.96	24.58
Price / Book	0.09	2.25	9.54	4.74
Net Income	-$621.95M	$5.67B	$1.07B	$1.07B
7 Day Performance	-33.62%	0.82%	-0.31%	0.99%
1 Month Performance	-54.21%	-2.75%	0.18%	0.86%
1 Year Performance	-95.57%	-10.35%	155.59%	25.19%

Cango Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CANG Cango	2.3385 of 5 stars	$0.20 -4.9%	$3.00 +1,416.7%	-95.5%	$36.97M	$688.08M	N/A	2,350	Gap Down
DAVA Endava	3.8409 of 5 stars	$2.69 flat	$7.43 +176.2%	-80.8%	$151.21M	$999.23M	N/A	11,479
AMBR Amber International	0.7077 of 5 stars	$1.55 +3.7%	N/A	N/A	$145.66M	$61.61M	N/A	1,190	News Coverage Positive News Gap Down
DOYU DouYu International	3.1309 of 5 stars	$4.53 -2.6%	$5.20 +14.8%	-28.4%	$136.72M	$546.09M	12.58	2,160	Positive News
HCAT Health Catalyst	3.9627 of 5 stars	$1.75 +1.5%	$2.77 +58.9%	-49.2%	$128.94M	$311.14M	N/A	1,200	Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:CANG) was last updated on 6/27/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cango (CANG) Competitors

CANG vs. DAVA, AMBR, DOYU, HCAT, and EXFY

How does Cango compare to Endava?

Summary

How does Cango compare to Amber International?

Summary

How does Cango compare to DouYu International?

Summary

How does Cango compare to Health Catalyst?

Summary

How does Cango compare to Expensify?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CANG vs. The Competition

Cango Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Cango (CANG) Competitors

CANG vs. DAVA, AMBR, DOYU, HCAT, and EXFY

How does Cango compare to Endava?

Do insiders & institutionals have more ownership in CANG or DAVA?

Does the media refer more to CANG or DAVA?

Which has preferable valuation & earnings, CANG or DAVA?

Do analysts recommend CANG or DAVA?

Is CANG or DAVA more profitable?

Which has more risk and volatility, CANG or DAVA?

Summary

How does Cango compare to Amber International?

Do analysts recommend AMBR or CANG?

Which has better valuation & earnings, AMBR or CANG?

Does the media prefer AMBR or CANG?

Do insiders and institutionals believe in AMBR or CANG?

Is AMBR or CANG more profitable?

Which has more volatility & risk, AMBR or CANG?

Summary

How does Cango compare to DouYu International?

Does the media refer more to CANG or DOYU?

Is CANG or DOYU more profitable?

Which has better valuation & earnings, CANG or DOYU?

Do analysts recommend CANG or DOYU?

Which has more risk and volatility, CANG or DOYU?

Do insiders & institutionals hold more shares of CANG or DOYU?

Summary

How does Cango compare to Health Catalyst?

Does the media prefer HCAT or CANG?

Do analysts rate HCAT or CANG?

Is HCAT or CANG more profitable?

Which has more risk and volatility, HCAT or CANG?

Do insiders and institutionals have more ownership in HCAT or CANG?

Which has preferable valuation and earnings, HCAT or CANG?

Summary

How does Cango compare to Expensify?

Does the media favor CANG or EXFY?

Which has more risk & volatility, CANG or EXFY?

Is CANG or EXFY more profitable?

Do insiders & institutionals have more ownership in CANG or EXFY?

Do analysts rate CANG or EXFY?

Which has preferable earnings & valuation, CANG or EXFY?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CANG vs. The Competition

Cango Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools